date,title,source
Oct-23-18,Clementia Announces Plan to Submit a New Drug Application for Palovarotene for the Treatment of FOP Based on Positive Phase 2 Results,GlobeNewswire
Oct-24-18,"Why Tupperware Brands, Lithia Motors, and Clementia Pharmaceuticals Jumped Today",Motley Fool
Oct-24-18,Biotech Stock Soars 35%: Clementia to File Bone Disorder NDA,Investopedia
